| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2106601 | Blood Reviews | 2010 | 6 Pages |
Abstract
Myeloproliferative disorders are commonly associated with thrombohemorrhagic manifestations. The current review highlights recent advances in understanding the epidemiology and pathogenetic mechanisms of thrombotic and bleeding complications. Therapeutic modalities and prophylactic interventions corresponding to the specific disease states are also discussed.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Emmanouil Papadakis, Ron Hoffman, Benjamin Brenner,